Development of monoclonal antibodies to prevent and treat infections from Flaviviruses

Ufuk Avrupa (Horizon Europe) · çağrı konusu HORIZON-HLTH-2027-01-DISEASE-06 (Cluster 1 - Health (Single stage - 2027/1)). Eylem türü: HORIZON Research and Innovation Actions.

Expected Outcome:

This topic aims at supporting activities that are enabling or contributing to one or several expected impacts of destination “Tackling diseases and reducing disease burden”. To that end, proposals under this topic should aim to deliver results that are directed at, tailored towards and contributing to all the following expected outcomes:

• The scientific and clinical communities have a better understanding of and access to experimental monoclonal antibodies for the prevention and treatment of emerging or re-emerging viral infections, as well as for further clinical investigation.
• Candidate monoclonal antibody therapies are available to treat patients for emerging and re-emerging viral infections, increasing therapeutic options for clinical deployment in case of an epidemic or pandemic.

Scope:

Infectious diseases remain a major threat to health and health security in the EU and globally. …

Kaynak: Avrupa Komisyonu Funding & Tenders Portal (otomatik aktarım; ayrıntı ve güncel koşullar için resmî sayfaya bakın).

"> General conditions

• Admissibility Conditions, proposal page limit and layout

Admissibility conditions are  described in Annex A and Annex E of the Horizon Europe Work Programme General Annexes.

Proposal page limits and layout are described in Part B of the Application Form available in the Submission System.

• Eligible Countries

Eligible countries are described in Annex B of the Work Programme General Annexes. …

Uygunluk: ülkenizin bu programa katılım durumunu ve ortaklık şartlarını resmî konu sayfasından teyit edin.